Relay Therapeutics is approaching a pivotal clinical catalyst with the zovegalisib Phase 1/2 data readout at ESMO TAT. Check ...

Obesity research has become increasingly relevant as global rates of overweight and obesity continue to rise, affecting all age groups and communities.

KOMZIFTI™ (ziftomenib) launch generating early revenue momentum and rapid payer coverage decisions – – Market feedback emphasizes differentiated safety, combinability and convenience of ziftomenib, su ...

Microvision (NASDAQ:MVIS) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline what Chief ...

Explore the controversial new research asking if autism is preventable and what scientists are discovering about developmental risks.